VRTX

Vertex Pharmaceuticals Incorporated (VRTX)

Last Price$471.270.0%

Market Cap$127.3bn

Financial profile score

7/10

LTM Revenue

$10.3 bn

+1.4% YoY

LTM Net Income

($0.5 bn)

-112.2% YoY

LTM Free Cash Flow

($1.4) bn

-141% YoY

Net Debt

($3.6) bn

Short-term financial position

2.5x

Current Assets / Current Liabilities

VRTX Income statement

Crunching data... Almost there!

Earnings growth (>10% annually)

VRTX's earnings have grown by 24.6% per year over the past 5 years.

Growing Net income margin

VRTX's net income margin has decreased (-0.4%) in the last year from (37.2%) to (36.8%)

VRTX Balance sheet

Crunching data... Almost there!

VRTX Key balance sheet metrics

Crunching data... Almost there!

VRTX Cash flow statement

Crunching data... Almost there!

VRTX Key cash flow statement metrics

Crunching data... Almost there!

Growing free cash flow margin

VRTX's free cash flow margin has decreased (-10.6%) in the last year from (44.0%) to (33.3%)

Discover more VRTX fundamentals

Stock picking tips. Ultimate guide 2024

Discover the secrets to successful stock picking in 2024! We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.

Sign up and get for free →

FAQ

What are Vertex Pharmaceuticals Incorporated (VRTX) Key Income Statement Metrics?

As of today, Vertex Pharmaceuticals Incorporated last 12-month Revenue is $10.3 bn , EBITDA is ($0 bn) and Net Income is ($0.5 bn) , based on the financial report for June 30, 2024 (Q2 2024).

What are Vertex Pharmaceuticals Incorporated (VRTX) Key Balance Sheet Metrics?

As of today, Vertex Pharmaceuticals Incorporated Total Assets are $20.1 bn and Total Liabilities are $5.4 bn , based on the financial report for June 30, 2024 (Q2 2024).

What are Vertex Pharmaceuticals Incorporated (VRTX) Key Cash Flow Statement Metrics?

As of today, Vertex Pharmaceuticals Incorporated last 12-month Cash Flow from Operating Activities is $-3.8 bn, Cash Flow from Investing Activities is $-0.5 bn and Cash Flow from Financing Activities is $-0.4 bn, based on the financial report for June 30, 2024 (Q2 2024).

What is Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow?

As of today, Vertex Pharmaceuticals Incorporated last 12-month Free Cash Flow is ($1.4) bn , based on the financial report for June 30, 2024 (Q2 2024).